Case series:off-the-shelf CART

3 trials

Sponsors

He'nan Province Cancer Hospital, Henan Province Cancer Hospital, The Second Affiliated Hospital of Zhejiang University

Conditions

DLBCLr/r B-ALL

Phase 1

Clinical Study on the Safety and Efficacy of Commercialized CD19CART Cells in the Treatment of Refractory, Invasive Non-Hodgkin's Lymphoma (NHL)

RecruitingChiCTR1800014956

The Second Affiliated Hospital of Zhejiang UniversityDLBCL

Start: 2018-02-25Updated: 2018-02-26

Clinical Study on the Safety and Efficacy of Commercialized CD19CART Cells in the Treatment of Refractory, Invasive Non-Hodgkin's Lymphoma (NHL)

RecruitingChiCTR1800014952

He'nan Province Cancer HospitalDLBCL

Start: 2018-02-24Updated: 2018-02-26

Clinical Study on the Safety and Efficacy of CD19CART Cell Therapy for Refractory B-Cell Leukemia

RecruitingChiCTR1800014953

Henan Province Cancer Hospitalr/r B-ALL

Start: 2018-02-24Updated: 2018-02-26